Comparison between AGS Transact Technologies IPO and Supriya Lifescience IPO.
AGS Transact Technologies IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Supriya Lifescience IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of AGS Transact Technologies IPO is up to ₹680.00 Cr whereas the issue size of the Supriya Lifescience IPO is up to ₹700.00 Cr. The final issue price of AGS Transact Technologies IPO is ₹175.00 per share and of Supriya Lifescience IPO is ₹274.00 per share.
| AGS Transact Technologies IPO | Supriya Lifescience IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹2 per share |
| Issue Price (Lower) | ₹166.00 per share | ₹265.00 per share |
| Issue Price (Upper) | ₹175.00 per share | ₹274.00 per share |
| Issue Price (Final) | ₹175.00 per share | ₹274.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 85 shares | 54 shares |
| Fresh Issue Size | 0 shares | 72,99,270 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹200.00 Cr |
| OFS Issue Size | 3,88,57,141 shares | 1,82,48,175 shares |
| OFS Issue Size (Amount) | up to ₹680.00 Cr | up to ₹500.00 Cr |
| Issue Size Total | 3,88,57,141 shares | 2,55,47,445 shares |
| Issue Size Total (Amount) | up to ₹680.00 Cr | up to ₹700.00 Cr |
AGS Transact Technologies IPO opens on Jan 19, 2022, while Supriya Lifescience IPO opens on Dec 16, 2021. The closing date of AGS Transact Technologies IPO and Supriya Lifescience IPO is Jan 21, 2022, and Dec 20, 2021, respectively.
| AGS Transact Technologies IPO | Supriya Lifescience IPO | |
|---|---|---|
| Anchor Bid Date | Jan 18, 2022 | Dec 15, 2021 |
| Issue Open | Jan 19, 2022 | Dec 16, 2021 |
| Issue Close | Jan 21, 2022 | Dec 20, 2021 |
| Basis Of Allotment (Tentative) | Jan 27, 2022 | Dec 23, 2021 |
| Initiation of Refunds (Tentative) | Jan 28, 2022 | Dec 24, 2021 |
| Credit of Share (Tentative) | Jan 31, 2022 | Dec 27, 2021 |
| Listing date (Tentative) | Jan 31, 2022 | Dec 28, 2021 |
| Anchor Lockin End date 1 | Feb 26, 2022 | Jan 22, 2022 |
| Anchor Lockin End date 2 | Apr 27, 2022 | Mar 23, 2022 |
AGS Transact Technologies IPO P/E ratio is , as compared to Supriya Lifescience IPO P/E ratio of .
| AGS Transact Technologies IPO | Supriya Lifescience IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 98.23 | 99.98 | ||||
| Promoter Shareholding (Post-Issue) | 66.07 | 68.24 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹2106.87 Cr. | ₹700.00 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ₹4.62 | |||||
| RoNW | 10.29 |
In the AGS Transact Technologies IPO Retail Individual Investors (RII) are offered 1,36,00,000 shares while in Supriya Lifescience IPO retail investors are offered 1,36,00,000 shares. Qualified Institutional Buyers (QIB) are offered 77,71,428 shares in AGS Transact Technologies IPO and 76,64,234 shares in Supriya Lifescience IPO.
| AGS Transact Technologies IPO | Supriya Lifescience IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,16,57,141 shares | 1,14,96,351 shares |
| Market Maker Reservation | ||
| QIB | 77,71,428 shares | 76,64,234 shares |
| NII | 58,28,572 shares | 38,32,116 shares |
| RII | 1,36,00,000 shares | 25,54,744 shares |
| Employee | ||
| Others | ||
| Total | 3,88,57,141 shares | 2,55,47,445 shares |
AGS Transact Technologies IPO subscribed 7.79x in total, whereas Supriya Lifescience IPO subscribed 71.51x.
| AGS Transact Technologies IPO | Supriya Lifescience IPO | |
|---|---|---|
| QIB (times) | 2.68x | 31.83x |
| NII (times) | 25.61x | 161.22x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 3.08x | 56.01x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 7.79x | 71.51x |
